Jump to content

Clinical Trial for KRAS


KatieB

Recommended Posts

KRAS Clinical Trial information: This trial is designed to evaluate how safe and effective the study drug known as abemaciclib is in participants with lung cancer. Specifically for people who have a confirmed diagnosis of stage IV non-small cell lung cancer (NSCLC) with a KRAS mutation and who have already received prior chemotherapy. http://www.lillytrialguide.com/juniper3

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.